Budapest, Hungary

Csilla Majláth


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Genius of Csilla Majláth

Introduction

Csilla Majláth, an accomplished inventor based in Budapest, Hungary, has made significant contributions to the field of chemistry. With one patent to her name, she exemplifies the dedication and creativity inherent in innovative work. Her patent work highlights her expertise in the synthesis of complex compounds, providing valuable advancements in pharmaceutical research.

Latest Patents

Csilla Majláth's patent focuses on a novel "Process for the preparation of 3-spiro'cyclohexan-1,3′-′3H!indolin-2′-one! derivatives." This innovative process involves the reaction of specific compounds in a water-inmiscible organic solvent, coupled with a phase transfer catalyst. Her method aims to produce a compound of formula (I) by dissolving compounds of formulas (II) and (III) and reacting them with either an aqueous solution of a base or a solid form of a base. The process provides versatility, allowing for the transformation of the resultant compound into its salt if desired.

Career Highlights

Csilla Majláth is currently associated with Sanofi-Aventis, a leading global pharmaceutical company. Her role as an inventor enables her to contribute to pioneering research and development efforts. Through her innovative endeavors, she seeks to improve drug formulations and synthesis techniques, thus enhancing the therapeutic options available in the healthcare industry.

Collaborations

Throughout her career, Csilla has collaborated with talented coworkers, including Eva Csikós and Csaba Gönczi. Together, they share insights, expertise, and a commitment to advancing scientific knowledge. Their collaborative efforts exemplify the importance of teamwork in driving innovation within the field.

Conclusion

Csilla Majláth stands as a beacon of innovation in the realm of chemistry. Her patent not only reflects her inventive spirit but also contributes to the broader scientific community's understanding of compound synthesis. As she continues her work at Sanofi-Aventis, her passion for innovation will undoubtedly lead to further advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…